ver the coming weeks on Oncology Central we will be carrying out a Spotlight event exploring the field of biosimilars in oncology. Join us as we look further into their development, evaluate the potential benefits alongside regulatory challenges and see whether there are sufficient resources available to clinicians who are considering adopting biosimilars.
This Spotlight will feature key features from peer-reviewed journals, exclusive interviews and features with key opinion leaders in the field.
Below you can find information on all the content associated with this Spotlight – we will be adding to it frequently, so be sure to keep checking back.
Exploring the trastuzumab biosimilar data: an interview with Richard Markus
Biosimilars in oncology: survey infographic
Biosimilar monoclonals have landed in oncology
ATMP and biosimilars: challenges and how to overcome them
Biosimilars: New hope for oncology sustainability
Biosimilars at work: Access. Experience. Science.ARTICLES | INSIGHTS | INTERVIEWS